OverviewChartNewsTraderScreen

Revance Therapeutics/  US7613301099  /

IEX
19/09/2024  21:59:59 Chg. -0.12 Volume Bid21:59:59 Ask21:59:59 High Low
5.86USD -2.01% 292,655
Turnover: 1.72 mill.		 5.85Bid Size: 11,978 5.86Ask Size: 22,480 6.04 5.72
GlobeNewswire 27/08 Structure Therapeutics Appoints Angus C. Russell to Board of Directors
GlobeNewswire 13/08 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, RVNC, BALY, DRQ on Behalf of Sharehold...
GlobeNewswire 13/08 SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Revance Therapeutics, Inc. –...
GlobeNewswire 12/08 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Revance The...
GlobeNewswire 12/08 RVNC Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Revance Therapeutic...
GlobeNewswire 28/03 ArriVent BioPharma Reports Full Year 2023 Financial Results
GlobeNewswire 05/11/2023 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revance Therapeu...
GlobeNewswire 27/10/2023 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revance Therapeu...
GlobeNewswire 19/10/2023 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revance Therapeu...
GlobeNewswire 25/09/2023 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Revance Therapeu...
GlobeNewswire 20/09/2023 ArriVent Appoints Chris Nolet to its Board of Directors
GlobeNewswire 08/02/2022 FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Re...
GlobeNewswire 08/02/2022 DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been F...
GlobeNewswire 07/02/2022 Final Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Dead...
GlobeNewswire 05/02/2022 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Revance Therapeutics (RVNC) Investors to Lead Plaint...
GlobeNewswire 04/02/2022 RVNC Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Revance Therapeutics, Inc. Invest...
GlobeNewswire 03/02/2022 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BLI, RAAS, RVNC INVESTORS of Lead Plaintiff Deadline in Class...
GlobeNewswire 03/02/2022 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rev...
GlobeNewswire 02/02/2022 ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors with Losses to S...
GlobeNewswire 02/02/2022 FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BLI, RAAS an...
GlobeNewswire 01/02/2022 DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investo...
GlobeNewswire 01/02/2022 SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS HOOD, MARA, RAAS, RVNC INVESTORS...
GlobeNewswire 01/02/2022 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revanc...
GlobeNewswire 31/01/2022 RVNC 8-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics ...
GlobeNewswire 29/01/2022 SHAREHOLDER ALERT: CLAIMSFILER REMINDS BLI, RAAS, RVNC INVESTORS of Lead Plaintiff Deadline in Class...